496765-32-3 Usage
Description
5-Quinoxalinemethanol is a heterocyclic aromatic alcohol with the molecular formula C9H8N2O. It is derived from the quinoxaline structure, featuring a hydroxyl group attached to the carbon atom adjacent to the nitrogen in the quinoxaline ring. This colorless to pale yellow solid is utilized in various applications due to its unique chemical properties.
Uses
Used in Organic Synthesis:
5-Quinoxalinemethanol is used as a versatile building block in the production of pharmaceuticals, agricultural chemicals, and other specialty chemicals. Its unique structure allows for the creation of a wide range of compounds with diverse applications.
Used in Pharmaceutical Industry:
5-Quinoxalinemethanol is used as a key intermediate in the synthesis of various pharmaceuticals. Its potential biological activities, such as anti-inflammatory and anti-cancer properties, make it a valuable component in the development of new drugs.
Used in Corrosion Inhibition:
5-Quinoxalinemethanol is used as a corrosion inhibitor for metals. Its ability to form complexes with metal surfaces helps protect them from corrosion, making it a useful additive in various industrial applications.
Used in Coordination Chemistry:
5-Quinoxalinemethanol is used as a complexing agent in coordination chemistry. Its ability to form stable complexes with metal ions allows for the development of new materials with unique properties and potential applications in various fields.
Check Digit Verification of cas no
The CAS Registry Mumber 496765-32-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,9,6,7,6 and 5 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 496765-32:
(8*4)+(7*9)+(6*6)+(5*7)+(4*6)+(3*5)+(2*3)+(1*2)=213
213 % 10 = 3
So 496765-32-3 is a valid CAS Registry Number.
496765-32-3Relevant articles and documents
MUSCARINIC ACETYLCHOLINE M1 RECEPTOR ANTAGONISTS
-
Paragraph 00413, (2020/01/08)
Provided herein are compounds which are useful as antagonists of the muscarinic acetylcholine receptor M1 (mAChR M1); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with muscarinic acetylcholine receptor dysfunction using the compounds and compositions.
